Exactus, Inc.
Exactus, Inc.
Share · US30066P2011 (OTC)
Overview
No Price
n/a
Company Profile for Exactus, Inc. Share
Exactus, Inc. produces and supplies hemp-derived ingredients and feminized hemp genetics. It provides cannabidiol (CBD) feminized genetics, high cannabigerol (CBG) feminized genetics, hemp-derived specialty ingredients, and white-label products to the cosmetic, wellness, food, beverage, pharmaceutical, and pet industries. The company's specialty ingredients include CBD, CBG, CBN, and CBC isolates; CBD and CBG distillates; CBD water-soluble; CBD and CBG biomass; CBD AND CBG flowers; and CBD crude oil. It also provides a range of custom manufactured specialty cannabinoid products, such as skincare products, pain creams, tinctures, bath bombs, soft gels, balms, pet products, supplements, and other products. The company is based in Delray Beach, Florida. Exactus, Inc. is a subsidiary of Ceed2Med, LLC.
AI Analysis of Exactus, Inc.
Click any analysis below to get instant AI insights from finAgent

Company Data

Name Exactus, Inc.
Company Exactus, Inc.
Website http://www.exactushemp.com
Primary Exchange OTC UTC
ISIN US30066P2011
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Alvaro Daniel Alberttis
Country United States of America
Currency USD
Employees -
Address 80 NE 4th Avenue, Delray Beach
IPO Date 2015-12-30

Ticker Symbols

Name Symbol
Over The Counter EXDI
More Shares
Investors who hold Exactus, Inc. also have the following shares in their portfolio:
KSK Co.,Ltd.
KSK Co.,Ltd. Share
MARSH+MCLENN 24/30
MARSH+MCLENN 24/30 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025